John Patin

4.6k total citations · 3 hit papers
12 papers, 3.3k citations indexed

About

John Patin is a scholar working on Psychiatry and Mental health, Hematology and Molecular Biology. According to data from OpenAlex, John Patin has authored 12 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Hematology and 2 papers in Molecular Biology. Recurrent topics in John Patin's work include Multiple Myeloma Research and Treatments (3 papers), Attention Deficit Hyperactivity Disorder (2 papers) and Cancer Treatment and Pharmacology (2 papers). John Patin is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Attention Deficit Hyperactivity Disorder (2 papers) and Cancer Treatment and Pharmacology (2 papers). John Patin collaborates with scholars based in United States, Australia and Greece. John Patin's co-authors include Robert Knight, Jerome B. Zeldis, Zhinuan Yu, Marta Olesnyckyj, Gilbert Honigfeld, Orrin Devinsky, Jesús F. San Miguel, Anna Dmoszyńska, Alessandro Corso and Jean‐Luc Harousseau and has published in prestigious journals such as New England Journal of Medicine, Neurology and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

John Patin

12 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

2007 1.1k citations Meletios Α. Dimopoulos, Andrew Spencer et al. New England Journal of Medicine profile →
Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

2007 925 citations Donna M. Weber, Christine Chen et al. New England Journal of Medicine profile →
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion

2006 893 citations Alan F. List, Gordon W. Dewald et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Patin United States	10	2.7k	1.8k	1.3k	656	294	12	3.3k
Ming Qi United States	25	1.8k 0.7×	1.8k 1.0×	1.5k 1.2×	369 0.6×	92 0.3×	106	3.8k
Bart Burington United States	14	1.1k 0.4×	1.2k 0.6×	513 0.4×	255 0.4×	129 0.4×	31	2.2k
Anita D’Souza United States	28	1.3k 0.5×	903 0.5×	1.1k 0.9×	321 0.5×	72 0.2×	217	2.6k
Christopher D. Turner United States	25	628 0.2×	777 0.4×	513 0.4×	837 1.3×	77 0.3×	67	2.5k
Dimitrios C. Ziogas Greece	26	482 0.2×	755 0.4×	913 0.7×	175 0.3×	77 0.3×	99	2.2k
Mark Layton United Kingdom	25	847 0.3×	368 0.2×	221 0.2×	562 0.9×	60 0.2×	71	1.8k
D. Geißler Austria	20	514 0.2×	259 0.1×	205 0.2×	205 0.3×	129 0.4×	67	1.4k
E Damasio Italy	23	552 0.2×	217 0.1×	417 0.3×	472 0.7×	40 0.1×	65	1.5k
Peter D. Cole United States	29	261 0.1×	408 0.2×	567 0.5×	301 0.5×	76 0.3×	135	2.6k
Jemily Malvar United States	26	369 0.1×	590 0.3×	496 0.4×	182 0.3×	28 0.1×	80	1.9k

Countries citing papers authored by John Patin

Since Specialization

Citations

This map shows the geographic impact of John Patin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Patin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Patin more than expected).

Fields of papers citing papers by John Patin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Patin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Patin. The network helps show where John Patin may publish in the future.

Co-authorship network of co-authors of John Patin

This figure shows the co-authorship network connecting the top 25 collaborators of John Patin. A scholar is included among the top collaborators of John Patin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Patin. John Patin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Dimopoulos, Meletios Α., Andrew Spencer, H. Miles Prince, et al.. (2007). Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma. New England Journal of Medicine. 357(21). 2123–2132. 1073 indexed citations breakdown →

Weber, Donna M., Christine Chen, Rubén Niesvizky, et al.. (2007). Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America. New England Journal of Medicine. 357(21). 2133–2142. 925 indexed citations breakdown →

List, Alan F., Gordon W. Dewald, John M. Bennett, et al.. (2006). Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion. New England Journal of Medicine. 355(14). 1456–1465. 893 indexed citations breakdown →

Silva, Raul, et al.. (2004). Open-Label Study of Dexmethylphenidate Hydrochloride in Children and Adolescents with Attention Deficit Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 14(4). 555–563. 13 indexed citations

Weiss, Margaret D., Michael Wasdell, & John Patin. (2004). A Post Hoc Analysis of d-threo-Methylphenidate Hydrochloride (Focalin) Versus d,l-threo-Methylphenidate Hydrochloride (Ritalin). Journal of the American Academy of Child & Adolescent Psychiatry. 43(11). 1415–1421. 15 indexed citations

Richardson, Paul G., Robert Schlossman, Sundar Jagannath, et al.. (2004). Thalidomide for Patients With Relapsed Multiple Myeloma After High-Dose Chemotherapy and Stem Cell Transplantation: Results of an Open-Label Multicenter Phase 2 Study of Efficacy, Toxicity, and Biological Activity. Mayo Clinic Proceedings. 79(7). 875–882. 96 indexed citations

Devinsky, Orrin, Gilbert Honigfeld, & John Patin. (1991). Clozapine‐related seizures. Neurology. 41(3). 369–369. 219 indexed citations

Jc, Ballenger, Susan A. McDonald, R. Dirk Noyes, et al.. (1991). The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder.. PubMed. 27(2). 171–47. 33 indexed citations

Honigfeld, Gilbert & John Patin. (1990). A Two-Year Clinical and Economic Follow-Up of Patients on Clozapine. Psychiatric Services. 41(8). 882–885. 52 indexed citations

10.

Patin, John, et al.. (1989). U.S.A. Trials of Dihydroergotamine Nasal Spray in the Acute Treatment of Migraine Headache. Cephalalgia. 9(10_suppl). 344–345. 6 indexed citations

11.

Andes, W. Abe, et al.. (1986). Coagulation Factor Concentrate Usage and the Risk of Lymphadenopathy: A Prospective Study. The American Journal of the Medical Sciences. 292(3). 142–146. 3 indexed citations

12.

Patin, John, et al.. (1984). Replicated evidence on the construct validity of the SCAG (Sandoz Clinical Assessment-Geriatric) scale. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 8(2). 293–306. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact